Makro Capital of America, Inc. v. UBS AG

436 F. Supp. 2d 1342, 2006 U.S. Dist. LEXIS 47289, 2006 WL 1867709
CourtDistrict Court, S.D. Florida
DecidedJune 29, 2006
Docket04-21917-CIV
StatusPublished
Cited by4 cases

This text of 436 F. Supp. 2d 1342 (Makro Capital of America, Inc. v. UBS AG) is published on Counsel Stack Legal Research, covering District Court, S.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Makro Capital of America, Inc. v. UBS AG, 436 F. Supp. 2d 1342, 2006 U.S. Dist. LEXIS 47289, 2006 WL 1867709 (S.D. Fla. 2006).

Opinion

AMENDED ORDER 1

ALTONAGA, District Judge.

THIS CAUSE came before the Court on Defendant, UBS AG’s (“UBS[’sj”) Motion to Dismiss the Amended Complaint [D.E. 79], filed on April 19, 2006. The dispute centers upon a chain of historical events dating back to the 1920s. The Court has carefully considered the parties’ written submissions and all applicable law.

I. BACKGROUND

Plaintiff, Makro Capital of America, Inc. (“Makro”), filed its initial Complaint against UBS on July 29, 2004 [D.E. 1]. The Complaint named UBS (and its predecessors in interest) and the United States of America (“United States”) as Defendants.

The actions giving rise to the Complaint began prior to World War II when a German company, I.G. Farben (“Farben”), founded I.G. Chemie (“Chemie”), a Swiss company, in 1928. (See Amended Complaint [D.E. 61] ¶21). Chemie, in turn, acquired numerous U.S. assets, which were primarily under the control of a U.S. holding company named General Aniline and Film Corporation (“GAF”). 2 {Id. at ¶ 23). In 1942, 3 the United States seized GAF’s assets, along with Chemie’s other U.S. assets, under the Trading with the Enemy Act, claiming that the assets belonged to Farben, a German company and, hence, an enemy combatant. (See Id. at ¶¶ 2, 4).

Following World War II, however, Chemie (which had since been renamed Internationale Industrie-und Handelsbeteiligungen AG (“interhandel”)) sought the return of its assets. (Am. Comp. ¶ 33). It claimed that the assets had been wrongfully seized, as it had broken ties with Farben by 1940 and was an autonomous Swiss company. {See Id. at ¶ 34). Chemie/Interhandel therefore argued that it had been erroneously classified by the United States as an enemy combatant. Makro claims that the split was a farce initiated to create the appearance that Farben and Chemie were separate entities when, in reality, Farben controlled Chemie/Interhandel. (I d. at ¶ 30).

Chemie/Interhandel initiated litigation in the United States in 1948, seeking the return of its assets. After 15 years of litigation Chemie/Interhandel reached a *1344 settlement agreement with the United States in 1963 (the agreement was approved by a district court in 1964). (Am. Comp. ¶ 42). The settlement netted the company approximately $122 million. (Id. at ¶ 43). Shortly after the settlement, Chemie/Interhandel merged with UBS, and UBS gained control of the settlement proceeds. (Id. at ¶ 4).

On July 29, 2004, Makro filed a Complaint against UBS and the United States claiming that it had “legal, contractual, and cognizable rights” to make claims on behalf of itself, Farben, Farben’s trustees, and other Farben shareholders. (Complaint ¶ 26.) The Complaint asserted the following five causes of action against UBS: (1) accounting; (2) imposition of constructive trust; (3) fraud; (4) misrepresentation; and (5) spoliation of evidence. Makro brought a claim for unjust enrichment and a claim seeking the release of documents against the United States.

Plaintiffs initial Complaint was dismissed in an order dated May 18, 2005. See Makro Capital of America, Inc. v. UBS AG, 372 F.Supp.2d 623 (S.D.Fla.2005). In the May 18, 2005 Order, the undersigned held as follows:

In this case, the Complaint contains no allegation that any individual Holocaust victim has transferred a chose in action to Makro or that Makro otherwise has legal rights to bring actions on behalf of Holocaust victims or their survivors. Rather, Makro has alleged that it has “legal, contractual, and cognizable rights” to make claims on behalf of itself, Farben, Farben’s trustees, and other Farben shareholders. These claims, as discussed above, are barred from recovery under § 39 of the Trading with the Enemy Act.
Finally, the fact that Makro seeks to prove with its newly discovered evidence-that I.G. Chemie was not an independent Swiss company after 1940 but rather an alter ego of Farben, a Nazi collaborator-is essentially the same conclusion that the U.S. government reached in 1942 and 1943 when it seized I.G. Chemie’s assets. It is also the same issue that Interhandel and the U.S. government litigated for almost 20 years between 1948 and 1966. Farben was denied leave to intervene in that litigation in 1958, and Makro alleges no facts now demonstrating that it has a right, on behalf of Farben or Farben’s shareholders or trustees, to disrupt the settlement reached by the United States and Interhandel in 1963.

Id. at 628. The Court granted Makro leave to amend its Complaint so that it could re-plead its claim as a qui tam 4 action. Id.

Makro’s Amended Complaint [D.E. 61], which was filed under seal 5 on June 27, 2005, arises from the same general facts underlying Makro’s original Complaint. However, in accordance with the Court’s instructions in the May 18, 2005 Order, the claim was prosecuted as a qui tam action on behalf of the United States pursuant to 31 U.S.C. § 3730. The Amended Complaint alleges that UBS (and its predecessors in interest) violated the False Claims Act, 31 U.S.C. § 3729. Specifically, Makro claims that UBS sought to recover the assets seized by the United States by concealing the true nature of the relationship *1345 that existed between Farben and Che-mie/Interhandel throughout World War II.

Before Makro filed its Amended Complaint (and while its initial Complaint was still pending), Dr. Ludwig Koch filed an action against UBS under the False Claims Act in the Eastern District of New York. The New York action (No. 05-CV-1518) was filed under seal on March 28, 2005 (approximately three months before Makro filed its Amended Complaint) 6 and is indisputably based upon the same factual predicate as is Makro’s suit. Dr. Koch sought to intervene in order to have this action transferred to New York; a request that was denied in this Court’s May 24, 2006 Order [D.E. 100],

UBS’s present Motion seeks to dismiss the Amended Complaint. UBS claims that the Court lacks subject matter jurisdiction because (1) another qui tam action based on the same underlying facts was filed prior to this action; and (2) the United States had evidence and/or information relating to the false claims prior to Makro’s filing of the qui tam action.

II. ANALYSIS

A. Legal Standard

A party may seek to dismiss a claim for lack of subject matter jurisdiction pursuant to Fed.R.Civ.P.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
436 F. Supp. 2d 1342, 2006 U.S. Dist. LEXIS 47289, 2006 WL 1867709, Counsel Stack Legal Research, https://law.counselstack.com/opinion/makro-capital-of-america-inc-v-ubs-ag-flsd-2006.